Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,111.18
(
0.67%
)
US TECH 100
25,961.61
(
0.73%
)
Dow Jones
49,507.33
(
0.12%
)
Brent Oil
95.87
(
0.90%
)
Bitcoin
78,812.01
(
3.25%
)
News Focus
News Focus

Replies to post #524 on NeuroSense Therapeutics Ltd (NRSN)

Replies to #524 on NeuroSense Therapeutics Ltd (NRSN)
icon url

runncoach

12/05/25 8:19 AM

#526 RE: McMagyar #524

They're never going to be able to start the P3 trial without significant dilution or a partnership.They've been waitng a full year over getting a partnership , so it's anyone's guess at this point.